Target Name: TUSC7
NCBI ID: G285194
Review Report on TUSC7 Target / Biomarker Content of Review Report on TUSC7 Target / Biomarker
TUSC7
Other Name(s): LSAMP-AS1 | LINC00902 | tumor suppressor candidate 7 | Tumor suppressor candidate 7 | NCRNA00295 | LSAMPAS3 | LSAMP-AS3

TUSC7: Potential Drug Target and Regulator of Cell Signaling Pathways

TUSC7 (also known as LSAMP-AS1) is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and brain. It is a member of the Src tyrosine kinase family and is involved in the regulation of cell signaling pathways. TUSC7 has been identified as a potential drug target and is currently being studied for its potential therapeutic uses.

TUSC7 is a protein that is characterized by its ability to interact with several different signaling pathways. It has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed. TUSC7 has been shown to promote the formation of new blood vessels in response to the growth factor platelet-derived growth factor (PDGF), which is a protein that is released by platelets in response to the presence of injured blood vessels.

In addition to its role in angiogenesis, TUSC7 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with several different signaling pathways, including the RAS/MAPK pathway and the PI3K/AKT pathway. The RAS/MAPK pathway is a signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival, while the PI3K/AKT pathway is a signaling pathway that is involved in the regulation of cellular signaling pathways, including cell survival and angiogenesis.

TUSC7 has also been shown to play a role in the regulation of inflammation. It has been shown to interact with several different signaling pathways, including the NF-kappa-B pathway and the TNF-伪 pathway. The NF-kappa-B pathway is a signaling pathway that is involved in the regulation of inflammation and inflammation-related processes, while the TNF-伪 pathway is a signaling pathway that is involved in the regulation of inflammation, pain, and stress.

Despite its potential role in several different signaling pathways, TUSC7 has not yet been shown to have any physiological functions or to be involved in any disease processes. Therefore, further research is needed to fully understand its role in the regulation of cell signaling pathways and its potential therapeutic uses.

In conclusion, TUSC7 is a protein that has been shown to play a role in several different signaling pathways, including the RAS/MAPK and PI3K/AKT pathways. It has also been shown to promote the formation of new blood vessels in response to the growth factor PDGF, and it has been shown to interact with several different signaling pathways, including the NF-kappa-B and TNF-伪 pathways. Further research is needed to fully understand its role in the regulation of cell signaling pathways and its potential therapeutic uses.

Protein Name: Tumor Suppressor Candidate 7

The "TUSC7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUSC7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TUSC8 | TUT1 | TUT4 | TUT7 | TVP23A | TVP23B | TVP23C | TVP23C-CDRT4 | TVP23CP2 | TWF1 | TWF2 | TWIST | TWIST1 | TWIST2 | TWNK | TWSG1 | TWSG1-DT | TXK | TXLNA | TXLNB | TXLNG | TXLNGY | TXN | TXN2 | TXNDC11 | TXNDC12 | TXNDC15 | TXNDC16 | TXNDC17 | TXNDC2 | TXNDC5 | TXNDC8 | TXNDC9 | TXNIP | TXNL1 | TXNL1P1 | TXNL4A | TXNL4B | TXNP6 | TXNRD1 | TXNRD2 | TXNRD3 | TXNRD3NB | TYK2 | TYMP | TYMS | TYMSOS | Type II Transmembrane serine protease | TYR | TYRO3 | TYRO3P | TYROBP | Tyrosine Kinase | Tyrosine-Protein Kinase ABL | Tyrosine-Protein Kinases Src | Tyrosyl-DNA phosphodiesterase TDP | TYRP1 | TYSND1 | TYW1 | TYW1B | TYW3 | U2 small nuclear ribonucleoprotein auxiliary factor | U2AF1 | U2AF1L4 | U2AF2 | U2SURP | U3 small nucleolar ribonucleoprotein (U3 snoRNP) complex | U5 small nuclear ribonucleoprotein complex | U7 snRNP complex | UACA | UAP1 | UAP1L1 | UBA1 | UBA2 | UBA3 | UBA5 | UBA52 | UBA52P1 | UBA6 | UBA6-DT | UBA7 | UBAC1 | UBAC2 | UBAC2-AS1 | UBALD1 | UBALD2 | UBAP1 | UBAP1L | UBAP2 | UBAP2L | UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A